In breast cancer cells two shorter isoforms of ERα have been described, ERα46 that lacks the A/B domain (11) and ERα36 that lacks both AF-1 and AF-2 transactivation domains and has an extra 27aa c-terminal domain (12, 13). Here, ESR1 is linked to breast carcinoma.